Jorge Mestre-Ferrandiz

11PUBLICATIONS
29CO-AUTHORS
PharmacogenomicsHealth and ecological risk assessmentApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Economic development policyClinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 07, 2026
Pricing Combination Therapies: A Systematic Review of Value Attribution, Cost-Sharing Mechanisms and Policy Frameworks.

|Jan 13, 2026
Transferable Exclusivity Extension Vouchers for Antimicrobials: Incentive Design, Implementation Challenges, and Policy Trade-Offs.

Mario García-Díaz, Jorge Mestre-Ferrándiz, Jaime Espín

|Nov 05, 2025
Cost-per-Responder Analysis of Bimekizumab (IL-17A/F Inhibitor) Against IL-Inhibitors for Psoriatic Arthritis in Spain, Based on Matching-Adjusted Indirect Comparisons.

Jorge Mestre-Ferrandiz, Victoria Navarro-Compán, Yoana Ivanova-Markova

|Aug 08, 2025
A Framework for Considering the Role of the Public Sector in R&D of Health Technology.

Juan Carlos Rejon-Parrilla, David Epstein, Jorge Mestre-Ferrandiz

|Jan 12, 2024
A Review of Current Approaches to Evaluating and Reimbursing New Medicines in a Subset of OECD Countries.

Néboa Zozaya, Javier Villaseca, Irene Fernández

|Aug 09, 2021
How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment.

Michael Schlander, Karla Hernandez-Villafuerte, Chih-Yuan Cheng

Pageof 2

Frequent Collaborators

3 joint publications

Jaime Espin

2 joint publications

Néboa Zozaya

2 joint publications

Michael M Hopkins

2 joint publications

Álvaro Hidalgo-Vega